Stockholm - Free Realtime Quote SEK

CellaVision AB (publ) (CEVI.ST)

198.20
+4.20
+(2.16%)
As of 11:30:49 AM GMT+2. Market Open.
Loading Chart for CEVI.ST
  • Previous Close 194.00
  • Open 190.80
  • Bid 198.20 x --
  • Ask 198.60 x --
  • Day's Range 190.80 - 199.40
  • 52 Week Range 147.80 - 302.00
  • Volume 8,887
  • Avg. Volume 26,676
  • Market Cap (intraday) 4.727B
  • Beta (5Y Monthly) 1.23
  • PE Ratio (TTM) 31.07
  • EPS (TTM) 6.38
  • Earnings Date Jul 17, 2025
  • Forward Dividend & Yield 2.50 (1.29%)
  • Ex-Dividend Date May 7, 2025
  • 1y Target Est 230.00

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides digital hematology microscopy solutions, covering analyzers and instruments; and hardware products, including in vitro diagnostics IVD for laboratories; smear makers, stainers, stains, and staining protocols; DIFF-Line, a hematology lab that handles a smaller amount daily blood samples, as well as consists of three instruments, such as CellaVision DC-1, RAL SmearBox, and RAL StainBox for smearing, staining, and analyzing peripheral blood smears. It also provides CellaVision DC-1 for performing blood cell differentials; and CellaVision DM1200 and CellaVision DM9600 to automate and simplify the process of performing blood and body fluid differentials. In addition, the company's CellaVision Peripheral Blood Application enables laboratories to automate, standardize and simplify morphological examination like peripheral blood smears; CellaVision Advanced RBC Application performs a more comprehensive examination for red blood cell morphology; CellaVision Body Fluid Application is for examination body fluid preparations; CellaVision CellAtlas is an app with morphology experts for series mini lectures on extensive cell image library introduction to cell morphology; CellaVision Remote Review Software removes restrictive geographical constraints from smear review process and performs better; CellaVision Server Software creates a single streamlined workflow within one or multiple testing sites; and CellaVision VET is a veterinary lab. It sells its products to hospitals and commercial laboratories. The company was incorporated in 1994 and is based in Lund, Sweden.

www.cellavision.com

228

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CEVI.ST

View More

Performance Overview: CEVI.ST

Trailing total returns as of 6/9/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

CEVI.ST
7.71%
OMX Stockholm 30 Index (^OMX)
1.47%

1-Year Return

CEVI.ST
21.29%
OMX Stockholm 30 Index (^OMX)
3.97%

3-Year Return

CEVI.ST
39.99%
OMX Stockholm 30 Index (^OMX)
23.26%

5-Year Return

CEVI.ST
24.02%
OMX Stockholm 30 Index (^OMX)
48.50%

Compare To: CEVI.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CEVI.ST

View More

Valuation Measures

Annual
As of 6/6/2025
  • Market Cap

    4.63B

  • Enterprise Value

    4.47B

  • Trailing P/E

    30.41

  • Forward P/E

    26.18

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.19

  • Price/Book (mrq)

    5.52

  • Enterprise Value/Revenue

    5.97

  • Enterprise Value/EBITDA

    22.80

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    20.34%

  • Return on Assets (ttm)

    12.14%

  • Return on Equity (ttm)

    19.05%

  • Revenue (ttm)

    747.94M

  • Net Income Avi to Common (ttm)

    152.12M

  • Diluted EPS (ttm)

    6.38

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    182.32M

  • Total Debt/Equity (mrq)

    2.74%

  • Levered Free Cash Flow (ttm)

    60.52M

Research Analysis: CEVI.ST

View More

Company Insights: CEVI.ST

Research Reports: CEVI.ST

View More

People Also Watch